3Newburger JW,Takahashi M,Gerber MA,et al.Diagnosis,treatment,and long-term management of Kawasaki disease:a statement forHealth Professionals from the Committee on Rheumatic Fever,Endo-carditis and Kawasaki Disease,Council on Cardiovascular Disease inthe Young,American Heart Association[J].Circulation,2004,110:2747-2771.
2Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis,treatment, and long-term management of Kawasaki disease: astatement for Health Professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.Circulation, 2004, 110: 2747-2771.
3Sonobe T, Am S, Imada Y, et al. The incidence of coronary artery abnormalities in incomplete Kawasaki disease. Pediatr Res, 2003,53 : 164.
4Ayuswa M, Sonobe T, Uemura S, et al. Revision of diagnostic guidelines for Kawasaki disease (the 5^th revised edition). Pediatr Int, 2005, 47:232-234.
5Freeman AF, Shulman ST. Issues in the diagnosis of Kawasaki disease. Frog Pediatr Cardiol, 2004, 19:123-128.
7C, enizi J, Miron D, Spiegel R, et al. Kawasaki disease in very young infants: high prevalence of atypical presentation and coronary arteritis. Clin Pediatr, 2003, 42:263-267.
8Witt MT, Minich LL, Bohnsack iF, et al. Kawasski disease: more patients are being diagnosed who do not meet American Heart Association criteria. Pediatrics, 1999, 104 : e10.
9Kawamura T, Wago M, Kawaguchi H, et al. Plasma brain natriuretic peptide concentrations in patients with Kawasaki disease.Pediatr Int, 2000, 42:241-248.
10Kurotobi S, Kawakami N, Shimizu K, et al. Brain natriuretic peptide as a hormonal marker of ventricular diastolic dysfunction in children with Kawasaki disease. Pediatr Cardiol, 2005, 26 : 425-430.
